Titto Idicula

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

Nicola Logallo, Vojtěch Novotný, Christopher Elnan Kvistad et al. · The Lancet Neurology · 2017 · 458 citations

Thrombosis, Endpoint Trial, Tenecteplase Versus Alteplase +13

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

Christopher Elnan Kvistad, Halvor Næss, Bernt Harald Helleberg et al. · The Lancet Neurology · 2022 · 191 citations

Thrombosis, Tenecteplase Versus Alteplase, Cardiovascular Disease +15

Admission C – reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The 'Bergen stroke study'

Titto Idicula, Jan Brøgger, Ulrike Waje‐Andreassen et al. · BMC Neurology · 2009 · 118 citations · Full text

Serum Albumin in Ischemic Stroke Patients: The Higher the Better

Titto Idicula, Ulrike Waje‐Andreassen, Jan Brøgger et al. · Cerebrovascular Diseases · 2009 · 89 citations

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke

Nicola Logallo, Christopher Elnan Kvistad, Aliona Nacu et al. · BMC Neurology · 2014 · 57 citations · Full text